Patents by Inventor John Reno

John Reno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMANIZED ANTIBODIES
    Publication number: 20140308269
    Abstract: Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of finding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of finding an ICAM-1 epitope are further provided.
    Type: Application
    Filed: November 18, 2013
    Publication date: October 16, 2014
    Applicant: Perlan Therapeutics, Inc.
    Inventors: Fang FANG, Lori Kohlstaedt, John Reno
  • Humanized antibodies
    Patent number: 8586712
    Abstract: Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of binding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of binding an ICAM-1 epitope are further provided.
    Type: Grant
    Filed: March 26, 2010
    Date of Patent: November 19, 2013
    Assignee: Perlan Therapeutics, Inc.
    Inventors: Fang Fang, Lori Kohlstaedt, John Reno
  • HUMANIZED ANTIBODIES
    Publication number: 20110044976
    Abstract: Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of binding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of binding an ICAM-1 epitope are further provided.
    Type: Application
    Filed: March 26, 2010
    Publication date: February 24, 2011
    Inventors: FANG FANG, LORI KOHLSTAEDT, JOHN RENO
  • Humanized antibodies
    Patent number: 7696324
    Abstract: Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of binding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of binding an ICAM-1 epitope are further provided.
    Type: Grant
    Filed: September 11, 2006
    Date of Patent: April 13, 2010
    Assignee: Perlan Therapeutics, Inc.
    Inventors: Fang Fang, Lori Kohlstaedt, John Reno
  • Humanized antibodies
    Publication number: 20070071742
    Abstract: Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of binding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of binding an ICAM-1 epitope are further provided.
    Type: Application
    Filed: September 11, 2006
    Publication date: March 29, 2007
    Inventors: Fang Fang, Lori Kohlstaedt, John Reno
  • Radiolabeled annexins
    Publication number: 20060029545
    Abstract: Radiolabeled annexin and modified annexin conjugates useful for imaging vascular thrombi are described. Methods for making and using such radiolabeled annexin conjugates are also provided.
    Type: Application
    Filed: September 27, 2005
    Publication date: February 9, 2006
    Inventors: Sudhakar Kasina, Alan Fritzberg, Jonathan Tait, John Reno
  • Methods of use of antibodies with reduced immunogenicity or toxicity
    Publication number: 20050100545
    Abstract: Humanized antibodies which bind the NR-LU-13 antigen, conjugates containing such antibodies, and their use in pretargeting methods and conventional antibody therapy and immunodiagnosis are provided.
    Type: Application
    Filed: July 31, 2003
    Publication date: May 12, 2005
    Applicant: NeoRx Corporation
    Inventors: Scott Graves, John Reno, Robert Mallett, Mark Hylarides
  • Radiolabeled annexins
    Publication number: 20050036948
    Abstract: Radiolabeled annexin and modified annexin conjugates useful for imaging vascular thrombi are described. Methods for making and using such radiolabeled annexin conjugates are also provided.
    Type: Application
    Filed: April 8, 2004
    Publication date: February 17, 2005
    Applicant: NeoRx Corporation
    Inventors: Sudhakar Kasina, John Reno, Louis Theodore
  • Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 and their use in pretargeting methods
    Publication number: 20050008635
    Abstract: Humanized antibodies which bind the NR-LU-13 antigen, conjugates containing such antibodies, and their use in pretargeting methods and conventional antibody therapy and immunodiagnosis are provided.
    Type: Application
    Filed: February 25, 2004
    Publication date: January 13, 2005
    Applicant: NeoRx Corporation
    Inventors: Scott Graves, John Reno, Robert Mallett, Mark Hylarides, Stephen Searle, Andrew Henry, Jan Pedersen, Anthony Rees
  • Humanized antibodies
    Publication number: 20030035798
    Abstract: Humanized antibodies that bind ICAM-1 are provided. Antibodies include those selected from: SEQ ID NO:1 and 3 (HumA); SEQ ID NO:5 and 7 (HumB); SEQ ID NO:9 and 11 (HumC); SEQ ID NO:13 and 15 (HumD); SEQ ID NO:17 and 19 (HumE); SEQ ID NO:21 and 23 (HumF); SEQ ID NO:25 and 27 (HumG); SEQ ID NO:29 and 31 (HumH); and SEQ ID NO:33 and 35 (HumI). Subsequences of the humanized antibodies capable of binding an ICAM-1 epitope are also provided. Methods of inhibiting pathogen infection (e.g., HRV) of a cell employing humanized antibodies capable of binding an ICAM-1 epitope are further provided.
    Type: Application
    Filed: July 19, 2001
    Publication date: February 20, 2003
    Inventors: Fang Fang, Lori Kohlstaedt, John Reno